Blockade of acute grade IV skin and eye graft-versus-host disease by anti-interleukin-2 receptor monoclonal antibody in genoidentical bone marrow transplantation setting
A six-year-old boy with homozygous beta-thalassemia in the favorable class 1 risk group received a bone marrow transplant, from his histocompatible sister. He developed grade IV skin and eye graft-versus-host disease (GVHD) following varicella zoster reactivation. Despite the appropriate prop...
Saved in:
| Main Authors: | H Ozşahin, P Tuchschmid, R Lauener, K Waldvogel, D Nadal, R A Seger |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Hacettepe University Institute of Child Health
1998-04-01
|
| Series: | The Turkish Journal of Pediatrics |
| Online Access: | https://turkjpediatr.org/article/view/3304 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
IL-1 Receptor Blockade Alleviates Graft-versus-Host Disease through Downregulation of an Interleukin-1β-Dependent Glycolytic Pathway in Th17 Cells
by: Min-Jung Park, et al.
Published: (2015-01-01) -
Development of murine model of allogeneic bone marrow transplantation and graft-versus-host disease
by: I. S. Moiseev, et al.
Published: (2016-12-01) -
Interleukin-6 and other cytokine blockade in COVID-19 hyperinflammation
by: Latika Gupta, et al.
Published: (2020-01-01) -
Membranous nephropathy associated with graft-versus-host disease in allogeneic bone marrow transplantation successfully treated with rituximab.
by: Jorge Quinchuela, et al.
Published: (2024-08-01) -
Treatment of refractory chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation with low-dose interleukin-2
by: I. S. Moiseev, et al.
Published: (2015-12-01)